+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Professor Rosalind Eeles
PhD FRCP FRCR
Clinical Oncology, Cancer Genetics - all cancers, Prostate cancers, Bladder cancers
Clinician & Genetictist; Head of the Cancer Genetics Clinical Unit at The Royal Marsden Hospital
Professor Ros Eeles is Professor of Oncogenetics at The Institute of Cancer Research, University of London UK. She trained at The University of Cambridge, UK and St Thomas' Hospital, London. She is a Fellow of the Royal College of Physicians and Royal College of Radiologists (Clinical Oncology Faculty), London UK. She is accredited in Clinical Oncology and has extensive sub specialist experience in Cancer Genetics.Professor Eeles' oncological practice is in radiotherapy and chemotherapy for Uro-Oncology. Her cancer genetics practice involves cancer risk assessment, screening advice and management of increased cancer risk. She is also an expert in how the new cancer genetics impacts on treatment decisions. She has edited a specialist textbook in Genetic Predisposition to Cancer which is in 2nd edition and is an author of over 238 original research papers. She has an international standing in Cancer Genetic Clinical Management and research, particularly management of individuals with mutations in the breast/ovarian/prostate cancer predisposition genes, BRCA1 and BRCA2 and genetic predisposition to prostate cancer. She has been on several genetics advisory committees and edited the special edition of Familial Cancer: 'Cancer Genetics: New Ways of Working' which reported on models of delivery of cancer genetics services.She is a member of the learned societies: ESTRO, ESMO, ASHG, AACR, BAUS, BBG, and CGG UK
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2017 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.